Response to ‘How to define disease severity accurately in patients with familial Mediterranean fever’
暂无分享，去创建一个
[1] E. Demirkaya,et al. How to define disease severity accurately in patients with familial Mediterranean fever , 2020, Rheumatology International.
[2] H. E. Sönmez,et al. Performance of Tel-Hashomer, Livneh, pediatric and new Eurofever/PRINTO classification criteria for familial Mediterranean fever in a referral center , 2019, Rheumatology International.
[3] H. E. Sönmez,et al. Profile of new referrals to a single pediatric rheumatology center in Turkey , 2019, Rheumatology International.
[4] E. Ben-Chetrit,et al. Development and initial validation of international severity scoring system for familial Mediterranean fever (ISSF) , 2016, Annals of the rheumatic diseases.
[5] S. Ozen,et al. Evaluation of the current disease severity scores in paediatric FMF: is it necessary to develop a new one? , 2012, Rheumatology.
[6] A. Bakkaloğlu,et al. Disease severity in children and adolescents with familial Mediterranean fever: a comparative study to explore environmental effects on a monogenic disease , 2008, Annals of the rheumatic diseases.
[7] A. Chetrit,et al. Evaluation of disease severity in familial Mediterranean fever. , 2005, Seminars in arthritis and rheumatism.
[8] M. Pras,et al. Clinical differences between North African and Iraqi Jews with familial Mediterranean fever. , 1998, American journal of medical genetics.